Abstract |
A methylcholanthrene-induced rat sarcoma propagated both in vitro and in vivo was used to examine the usefulness of a rapid biochemical in situ assay that measures thymidylate synthase (TS) activity in whole cells to predict sensitivity and resistance to the folate antagonists methotrexate (MTX), 10-ethyl-10-deazaaminopterin (10-EDAM) and trimetrexate (TMTX). There was an excellent correlation between the effects of these drugs on inhibiting TS and cytotoxicity as measured by a clonogenic assay, when the exposure time was 4 hr and those when the rat sarcoma cell line was employed (p less than 0.001). When tumor-cell suspensions were prepared from the rat sarcoma propagated in vivo, they were less sensitive to these antifolates, but the relative effectiveness of the 3 antifolates was similar: TMTX much greater than 10-EDAM greater than MTX. As expected, continuous exposure (10 to 12 days) produced cytotoxicity at a much lower dose of these drugs. When the 3 drugs were tested for anti- tumor effectiveness in rats bearing this tumor, the tumor regression measured was best with TMTX; 10-EDAM was intermediate in effectiveness as compared with MTX. These results indicate that the in situ TS assay and clonogenic assay may be used to predict anti- tumor efficacy of antifolates in vivo in this rat sarcoma.
|
Authors | W W Li, J T Lin, Y M Chang, B Schweitzer, J R Bertino |
Journal | International journal of cancer
(Int J Cancer)
Vol. 49
Issue 2
Pg. 234-8
(Sep 09 1991)
ISSN: 0020-7136 [Print] United States |
PMID | 1831805
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Folic Acid Antagonists
- Quinazolines
- Methylcholanthrene
- Thymidylate Synthase
- edatrexate
- Aminopterin
- Trimetrexate
- Methotrexate
|
Topics |
- Aminopterin
(analogs & derivatives, therapeutic use)
- Animals
- Drug Screening Assays, Antitumor
- Folic Acid Antagonists
(therapeutic use)
- Male
- Methotrexate
(therapeutic use)
- Methylcholanthrene
- Quinazolines
(therapeutic use)
- Rats
- Sarcoma, Experimental
(chemically induced, drug therapy, enzymology)
- Thymidylate Synthase
(analysis)
- Trimetrexate
|